Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Qiang He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5007-5225; OpenAlex author ID A5100632050, A5125115362. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 5 papers

Papers 11

  1. Conversion therapy with arterial reconstruction: Redefining the resect-ability of locally advanced pancreatic cancer. Co-author DOI 10.1016/j.hbpd.2026.05.001↗
  2. The interplay between tumor-intrinsic KRT6A and host-derived immune-nutritional status (PNI) defines prognosis in resectable PDAC. Last author DOI 10.1038/s41598-026-51645-1↗
  3. Comprehensive comparisons of total pancreatectomy versus pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a double-center, retrospective study. Last author DOI 10.21037/gs-2025-aw-544↗
  4. Correction: Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adeno… Co-author DOI 10.3389/fonc.2026.1852367↗
  5. Androgen-induced gene 1 correlates with extracellular vesicle-associated cholesterol metabolism and hepatic metastasis of pancreatic cancer Last author DOI 10.3748/wjg.121007↗
  6. Development and validation of a predictive model for portal-systemic venous invasion grading in borderline resectable pancreatic cancer. Co-author DOI 10.3748/wjg.v31.i42.112354↗
  7. Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1112576↗
  8. Impact of the lymph-node parameter on prognosis of patients with pancreatic ductal adenocarcinoma after radical resection. Last author DOI 10.1016/j.asjsur.2022.04.041↗
  9. Reconstructing spleno-mesenterico-portal cofluence by bifurcated allogeneic vein in local advanced pancreatic cancer-a feasible method to avoid left-sided port… Co-author DOI 10.1002/cam4.4093↗
  10. Risk factors related to metastasis of para-aortic lymph nodes in pancreatic ductal adenocarcinoma: A retrospective observational study. Last author DOI 10.1097/md.0000000000012370↗
  11. Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer. Last author DOI 10.1111/jgh.13299↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shaocheng Lyu · 7 shared papers, 2023–2026 · strength 2.08
  2. Ren Lang · 7 shared papers, 2021–2026 · strength 1.92
  3. Fangfei Wang · 4 shared papers, 2022–2026 · strength 1.01
  4. Fang-Fei Wang · 3 shared papers, 2025–2026 · strength 0.96
  5. Xin Zhao · 2 shared papers, 2026 · strength 0.61
  6. Xin Zhao · 2 shared papers, 2023–2025 · strength 0.50
  7. Hua Fan · 3 shared papers, 2016–2021 · strength 0.34
  8. Weiwei Shao · 1 shared paper, 2026 · strength 0.33
  9. Yun-Zhao Luo · 1 shared paper, 2026 · strength 0.32
  10. Zhangyong Ren · 1 shared paper, 2026 · strength 0.28
  11. Xingmao Zhang · 2 shared papers, 2018–2021 · strength 0.28
  12. Junming Xu · 1 shared paper, 2022 · strength 0.22
  13. Zhe Liu · 1 shared paper, 2023 · strength 0.17
  14. Zhangyong Ren · 1 shared paper, 2023 · strength 0.17
  15. Xing‐mao Zhang · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.